ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: A rationale for safer glucocorticoid replacement therapy.

MLA

Nixon, Mark, et al. “ABCC1 Confers Tissue-Specific Sensitivity to Cortisol versus Corticosterone: A Rationale for Safer Glucocorticoid Replacement Therapy.” Science Translational Medicine, vol. 8, no. 352, Aug. 2016, p. 352ra109. EBSCOhost, https://doi.org/10.1126/scitranslmed.aaf9074.

APA

Nixon, M., Mackenzie, S. D., Taylor, A. I., Homer, N. Z. M., Livingstone, D. E., Mouras, R., Morgan, R. A., Mole, D. J., Stimson, R. H., Reynolds, R. M., Elfick, A. P. D., Andrew, R., & Walker, B. R. (2016). ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: A rationale for safer glucocorticoid replacement therapy. Science Translational Medicine, 8(352), 352ra109. https://doi.org/10.1126/scitranslmed.aaf9074

Chicago

Nixon, Mark, Scott D Mackenzie, Ashley I Taylor, Natalie Z M Homer, Dawn E Livingstone, Rabah Mouras, Ruth A Morgan, et al. 2016. “ABCC1 Confers Tissue-Specific Sensitivity to Cortisol versus Corticosterone: A Rationale for Safer Glucocorticoid Replacement Therapy.” Science Translational Medicine 8 (352): 352ra109. doi:10.1126/scitranslmed.aaf9074.